Alice I Sato
Overview
Explore the profile of Alice I Sato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gross R, Thaweethai T, Kleinman L, Snowden J, Rosenzweig E, Milner J, et al.
JAMA
. 2024 Aug;
PMID: 39196964
Importance: Most research to understand postacute sequelae of SARS-CoV-2 infection (PASC), or long COVID, has focused on adults, with less known about this complex condition in children. Research is needed...
2.
Gross R, Thaweethai T, Rosenzweig E, Chan J, Chibnik L, Cicek M, et al.
PLoS One
. 2024 May;
19(5):e0285635.
PMID: 38713673
Importance: The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae of SARS-CoV-2 [PASC] or "Long COVID") in children and young adults remain unknown. Studies must address the urgent need...
3.
Neemann K, Sato A
Transpl Infect Dis
. 2023 Jul;
25 Suppl 1:e14100.
PMID: 37436808
Children who are immune compromised are uniquely threatened by a higher risk of infections, including vaccine-preventable diseases (VPDs). Children who undergo chemotherapy or cellular therapies may not have preexisting immunity...
4.
Gross R, Thaweethai T, Rosenzweig E, Chan J, Chibnik L, Cicek M, et al.
medRxiv
. 2023 May;
PMID: 37214806
Importance: The prevalence, pathophysiology, and long-term outcomes of COVID-19 (post-acute sequelae of SARS-CoV-2 [PASC] or "Long COVID") in children and young adults remain unknown. Studies must address the urgent need...
5.
Miri A, Sato A, Sewell R, Huang-Pacheco A
Am J Case Rep
. 2021 May;
22:e929892.
PMID: 34032782
BACKGROUND Anti-TNF-alpha therapies were the first class of biologics to be used in treatment of moderate to severe IBD. Immunosuppression status that develops from using anti-TNF-a therapies increases the risk...
6.
Shane A, Sato A, Kao C, Adler-Shohet F, Vora S, Auletta J, et al.
J Pediatric Infect Dis Soc
. 2020 Aug;
9(5):596-608.
PMID: 32840614
Understanding the role that children play in the clinical burden and propagation of severe acute respiratory syndrome coronavirus 2, responsible for coronavirus disease 2019 (COVID-19) infections, is emerging. While the...
7.
Huang B, Pan P, Li Q, Sato A, Levy D, Bromberg J, et al.
Cancer Res
. 2006 Jan;
66(2):1123-31.
PMID: 16424049
The accumulation of myeloid suppressor cells (MSCs) is associated with immune suppression in tumor-bearing mice and in cancer patients. The suppressive activity of MSC correlates with the expression of the...
8.
Xu D, Gu P, Pan P, Li Q, Sato A, Chen S
Int J Cancer
. 2004 Mar;
109(4):499-506.
PMID: 14991570
In previous reports, systemic administration of a stimulatory monoclonal antibody directed against the 4-1BB receptor had no effect on survival or tumor burden in mice inoculated with the poorly immunogenic...